NewsSource: EClinCloud

EClinCloud Product Overview | EDC · Clinical Trial Electronic Data Capture System

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration



EClinCloud EDC (Electronic Data Capture) is a next-generation electronic data capture system for clinical trials. Combining the strengths of multiple international EDC systems and optimized for the workflows of domestic and international users, it provides enterprises with a comprehensive cloud service solution that enables electronic capture, intelligent processing, and remote review of clinical trial data while ensuring transparent data standards, thereby improving clinical trial efficiency and data quality.


EDC

One-Stop Product + Service Solution





1

What Can EClinCloud Provide?

1

EDC System

2

System Operation Training and Qualification Certification

3

Database Build Services

4

End-to-End Project Management


2

Features of the EClinCloud EDC System


1

Efficient, easy-to-learn database build supporting diverse form configurations, with simple setup to embed complex edit checks

2

Intelligent data capture and quality control to safeguard quality and improve efficiency

3

Multi-dimensional data presentation supporting data report visualization and custom reports

4

Interoperability with other systems through field mapping and standard URL interface configuration




3

Why Choose EClinCloud EDC?

Article illustration

Intuitive user interface ensuring easy configuration and a low learning curve

AI-enabled, intelligent, convenient, and highly usable, reducing manual operational errors and accelerating project delivery

Ensures that security during database modification operations is rigorously verified, enhancing data management flexibility and reliability

Ensures strict data access control and granular user permission authorization, and provides SOP system certification to strengthen data protection






About EClinCloud

EClinCloud is a technology company dedicated to clinical R&D. It provides an integrated, interoperable all-in-one clinical trial cloud platform (including technical products and offerings such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, as well as solutions within them such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) along with clinical trial endpoint assessment technologies across different therapeutic areas (including central nervous system, ophthalmology, and others). By combining cutting-edge technology with life sciences data, EClinCloud is building a globally leading, "patient-centric" SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.







Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.